nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFS2—Doxorubicin—urinary bladder cancer	0.177	0.322	CbGbCtD
Metformin—NDUFS3—Doxorubicin—urinary bladder cancer	0.177	0.322	CbGbCtD
Metformin—NDUFS7—Doxorubicin—urinary bladder cancer	0.177	0.322	CbGbCtD
Metformin—SLC22A2—Cisplatin—urinary bladder cancer	0.0195	0.0354	CbGbCtD
Metformin—NDUFA2—Podofilox—Etoposide—urinary bladder cancer	0.00192	0.447	CbGdCrCtD
Metformin—NDUFA7—Azacitidine—Gemcitabine—urinary bladder cancer	0.000909	0.212	CbGdCrCtD
Metformin—NDUFA2—Azacitidine—Gemcitabine—urinary bladder cancer	0.000773	0.18	CbGdCrCtD
Metformin—NDUFA2—smooth muscle tissue—urinary bladder cancer	0.000771	0.00384	CbGeAlD
Metformin—NDUFB4—seminal vesicle—urinary bladder cancer	0.000768	0.00383	CbGeAlD
Metformin—NDUFAB1—seminal vesicle—urinary bladder cancer	0.000763	0.00381	CbGeAlD
Metformin—NDUFA8—seminal vesicle—urinary bladder cancer	0.000758	0.00378	CbGeAlD
Metformin—NDUFB9—seminal vesicle—urinary bladder cancer	0.000758	0.00378	CbGeAlD
Metformin—ND4—renal system—urinary bladder cancer	0.000757	0.00378	CbGeAlD
Metformin—PRKAB1—prostate gland—urinary bladder cancer	0.000755	0.00376	CbGeAlD
Metformin—NDUFA4—seminal vesicle—urinary bladder cancer	0.000754	0.00376	CbGeAlD
Metformin—NDUFV1—seminal vesicle—urinary bladder cancer	0.000749	0.00374	CbGeAlD
Metformin—NDUFB11—seminal vesicle—urinary bladder cancer	0.000749	0.00374	CbGeAlD
Metformin—NDUFS5—seminal vesicle—urinary bladder cancer	0.000745	0.00371	CbGeAlD
Metformin—NDUFB8—seminal vesicle—urinary bladder cancer	0.000745	0.00371	CbGeAlD
Metformin—NDUFA2—renal system—urinary bladder cancer	0.000742	0.0037	CbGeAlD
Metformin—SLC29A4—vagina—urinary bladder cancer	0.00074	0.00369	CbGeAlD
Metformin—NDUFA10—smooth muscle tissue—urinary bladder cancer	0.000735	0.00367	CbGeAlD
Metformin—NDUFC1—smooth muscle tissue—urinary bladder cancer	0.000729	0.00364	CbGeAlD
Metformin—NDUFB2—smooth muscle tissue—urinary bladder cancer	0.000723	0.0036	CbGeAlD
Metformin—NDUFA13—female reproductive system—urinary bladder cancer	0.000717	0.00358	CbGeAlD
Metformin—NDUFA9—female reproductive system—urinary bladder cancer	0.000717	0.00358	CbGeAlD
Metformin—NDUFC2—prostate gland—urinary bladder cancer	0.000711	0.00355	CbGeAlD
Metformin—ND6—smooth muscle tissue—urinary bladder cancer	0.000711	0.00355	CbGeAlD
Metformin—NDUFA10—renal system—urinary bladder cancer	0.000708	0.00353	CbGeAlD
Metformin—NDUFA1—female reproductive system—urinary bladder cancer	0.000706	0.00352	CbGeAlD
Metformin—NDUFB3—smooth muscle tissue—urinary bladder cancer	0.000705	0.00352	CbGeAlD
Metformin—NDUFB2—renal system—urinary bladder cancer	0.000696	0.00347	CbGeAlD
Metformin—NDUFA12—epithelium—urinary bladder cancer	0.000694	0.00346	CbGeAlD
Metformin—NDUFAF1—renal system—urinary bladder cancer	0.00069	0.00344	CbGeAlD
Metformin—NDUFC1—urethra—urinary bladder cancer	0.000689	0.00344	CbGeAlD
Metformin—NDUFB3—Azacitidine—Gemcitabine—urinary bladder cancer	0.000689	0.161	CbGdCrCtD
Metformin—NDUFV2—female reproductive system—urinary bladder cancer	0.000685	0.00342	CbGeAlD
Metformin—ND6—renal system—urinary bladder cancer	0.000684	0.00341	CbGeAlD
Metformin—NDUFS2—prostate gland—urinary bladder cancer	0.000684	0.00341	CbGeAlD
Metformin—NDUFB6—smooth muscle tissue—urinary bladder cancer	0.000684	0.00341	CbGeAlD
Metformin—NDUFB3—renal system—urinary bladder cancer	0.000679	0.00339	CbGeAlD
Metformin—NDUFS1—smooth muscle tissue—urinary bladder cancer	0.000679	0.00338	CbGeAlD
Metformin—NDUFAF1—urethra—urinary bladder cancer	0.000678	0.00338	CbGeAlD
Metformin—NDUFS3—prostate gland—urinary bladder cancer	0.000675	0.00337	CbGeAlD
Metformin—NDUFA12—smooth muscle tissue—urinary bladder cancer	0.000669	0.00334	CbGeAlD
Metformin—NDUFB7—smooth muscle tissue—urinary bladder cancer	0.000669	0.00334	CbGeAlD
Metformin—NDUFA4L2—female reproductive system—urinary bladder cancer	0.000667	0.00333	CbGeAlD
Metformin—NDUFAF2—urethra—urinary bladder cancer	0.000667	0.00333	CbGeAlD
Metformin—NDUFB3—urethra—urinary bladder cancer	0.000667	0.00333	CbGeAlD
Metformin—NDUFB1—smooth muscle tissue—urinary bladder cancer	0.000664	0.00331	CbGeAlD
Metformin—NDUFS8—smooth muscle tissue—urinary bladder cancer	0.000664	0.00331	CbGeAlD
Metformin—NDUFA5—renal system—urinary bladder cancer	0.000663	0.00331	CbGeAlD
Metformin—NDUFA11—renal system—urinary bladder cancer	0.000663	0.00331	CbGeAlD
Metformin—NDUFAB1—epithelium—urinary bladder cancer	0.000663	0.00331	CbGeAlD
Metformin—NDUFB9—epithelium—urinary bladder cancer	0.000659	0.00329	CbGeAlD
Metformin—NDUFA6—smooth muscle tissue—urinary bladder cancer	0.000655	0.00327	CbGeAlD
Metformin—NDUFB5—smooth muscle tissue—urinary bladder cancer	0.000655	0.00327	CbGeAlD
Metformin—NDUFS1—renal system—urinary bladder cancer	0.000653	0.00326	CbGeAlD
Metformin—NDUFA11—urethra—urinary bladder cancer	0.000651	0.00325	CbGeAlD
Metformin—NDUFS4—smooth muscle tissue—urinary bladder cancer	0.000651	0.00325	CbGeAlD
Metformin—NDUFB10—renal system—urinary bladder cancer	0.000649	0.00324	CbGeAlD
Metformin—NDUFS5—epithelium—urinary bladder cancer	0.000647	0.00323	CbGeAlD
Metformin—NDUFAF4—urethra—urinary bladder cancer	0.000647	0.00322	CbGeAlD
Metformin—NDUFB6—urethra—urinary bladder cancer	0.000647	0.00322	CbGeAlD
Metformin—NDUFB7—renal system—urinary bladder cancer	0.000644	0.00321	CbGeAlD
Metformin—NDUFA12—renal system—urinary bladder cancer	0.000644	0.00321	CbGeAlD
Metformin—NDUFB4—smooth muscle tissue—urinary bladder cancer	0.000643	0.00321	CbGeAlD
Metformin—NDUFB1—renal system—urinary bladder cancer	0.00064	0.00319	CbGeAlD
Metformin—NDUFS8—renal system—urinary bladder cancer	0.00064	0.00319	CbGeAlD
Metformin—NDUFAB1—smooth muscle tissue—urinary bladder cancer	0.000639	0.00319	CbGeAlD
Metformin—PRKAB1—seminal vesicle—urinary bladder cancer	0.000638	0.00318	CbGeAlD
Metformin—NDUFB10—urethra—urinary bladder cancer	0.000637	0.00318	CbGeAlD
Metformin—NDUFB9—smooth muscle tissue—urinary bladder cancer	0.000635	0.00317	CbGeAlD
Metformin—NDUFA8—smooth muscle tissue—urinary bladder cancer	0.000635	0.00317	CbGeAlD
Metformin—NDUFB7—urethra—urinary bladder cancer	0.000633	0.00316	CbGeAlD
Metformin—NDUFA12—urethra—urinary bladder cancer	0.000633	0.00316	CbGeAlD
Metformin—NDUFB5—renal system—urinary bladder cancer	0.000631	0.00315	CbGeAlD
Metformin—NDUFA6—renal system—urinary bladder cancer	0.000631	0.00315	CbGeAlD
Metformin—NDUFA4—smooth muscle tissue—urinary bladder cancer	0.000631	0.00315	CbGeAlD
Metformin—NDUFB1—urethra—urinary bladder cancer	0.000628	0.00313	CbGeAlD
Metformin—NDUFS8—urethra—urinary bladder cancer	0.000628	0.00313	CbGeAlD
Metformin—NDUFV1—smooth muscle tissue—urinary bladder cancer	0.000627	0.00313	CbGeAlD
Metformin—NDUFB11—smooth muscle tissue—urinary bladder cancer	0.000627	0.00313	CbGeAlD
Metformin—ND5—female reproductive system—urinary bladder cancer	0.000627	0.00313	CbGeAlD
Metformin—ND3—female reproductive system—urinary bladder cancer	0.000627	0.00313	CbGeAlD
Metformin—ND2—female reproductive system—urinary bladder cancer	0.000627	0.00313	CbGeAlD
Metformin—ND4L—female reproductive system—urinary bladder cancer	0.000627	0.00313	CbGeAlD
Metformin—NDUFS4—renal system—urinary bladder cancer	0.000627	0.00313	CbGeAlD
Metformin—NDUFS5—smooth muscle tissue—urinary bladder cancer	0.000623	0.00311	CbGeAlD
Metformin—NDUFB8—smooth muscle tissue—urinary bladder cancer	0.000623	0.00311	CbGeAlD
Metformin—NDUFB5—urethra—urinary bladder cancer	0.00062	0.00309	CbGeAlD
Metformin—NDUFA6—urethra—urinary bladder cancer	0.00062	0.00309	CbGeAlD
Metformin—NDUFB4—renal system—urinary bladder cancer	0.000619	0.00309	CbGeAlD
Metformin—NDUFS4—urethra—urinary bladder cancer	0.000616	0.00307	CbGeAlD
Metformin—NDUFAB1—renal system—urinary bladder cancer	0.000615	0.00307	CbGeAlD
Metformin—NDUFB9—renal system—urinary bladder cancer	0.000611	0.00305	CbGeAlD
Metformin—NDUFA8—renal system—urinary bladder cancer	0.000611	0.00305	CbGeAlD
Metformin—NDUFB4—urethra—urinary bladder cancer	0.000608	0.00303	CbGeAlD
Metformin—NDUFA4—renal system—urinary bladder cancer	0.000607	0.00303	CbGeAlD
Metformin—ND4—female reproductive system—urinary bladder cancer	0.000607	0.00303	CbGeAlD
Metformin—NDUFAB1—urethra—urinary bladder cancer	0.000604	0.00301	CbGeAlD
Metformin—NDUFB11—renal system—urinary bladder cancer	0.000604	0.00301	CbGeAlD
Metformin—NDUFV1—renal system—urinary bladder cancer	0.000604	0.00301	CbGeAlD
Metformin—NDUFA4L2—vagina—urinary bladder cancer	0.000603	0.00301	CbGeAlD
Metformin—NDUFC2—seminal vesicle—urinary bladder cancer	0.000602	0.003	CbGeAlD
Metformin—NDUFB9—urethra—urinary bladder cancer	0.0006	0.00299	CbGeAlD
Metformin—NDUFA8—urethra—urinary bladder cancer	0.0006	0.00299	CbGeAlD
Metformin—NDUFB8—renal system—urinary bladder cancer	0.0006	0.00299	CbGeAlD
Metformin—NDUFS5—renal system—urinary bladder cancer	0.0006	0.00299	CbGeAlD
Metformin—NDUFA4—urethra—urinary bladder cancer	0.000597	0.00298	CbGeAlD
Metformin—NDUFA2—female reproductive system—urinary bladder cancer	0.000594	0.00296	CbGeAlD
Metformin—NDUFV1—urethra—urinary bladder cancer	0.000593	0.00296	CbGeAlD
Metformin—NDUFB11—urethra—urinary bladder cancer	0.000593	0.00296	CbGeAlD
Metformin—NDUFB8—urethra—urinary bladder cancer	0.00059	0.00294	CbGeAlD
Metformin—NDUFS5—urethra—urinary bladder cancer	0.00059	0.00294	CbGeAlD
Metformin—NDUFS2—seminal vesicle—urinary bladder cancer	0.000578	0.00288	CbGeAlD
Metformin—NDUFS3—seminal vesicle—urinary bladder cancer	0.000571	0.00285	CbGeAlD
Metformin—NDUFA10—female reproductive system—urinary bladder cancer	0.000567	0.00283	CbGeAlD
Metformin—NDUFS7—renal system—urinary bladder cancer	0.000562	0.0028	CbGeAlD
Metformin—ND1—prostate gland—urinary bladder cancer	0.000561	0.0028	CbGeAlD
Metformin—NDUFB2—female reproductive system—urinary bladder cancer	0.000557	0.00278	CbGeAlD
Metformin—NDUFAF1—female reproductive system—urinary bladder cancer	0.000553	0.00276	CbGeAlD
Metformin—ND6—female reproductive system—urinary bladder cancer	0.000548	0.00273	CbGeAlD
Metformin—NDUFB3—female reproductive system—urinary bladder cancer	0.000544	0.00271	CbGeAlD
Metformin—NDUFA2—vagina—urinary bladder cancer	0.000538	0.00268	CbGeAlD
Metformin—NDUFA5—female reproductive system—urinary bladder cancer	0.000531	0.00265	CbGeAlD
Metformin—NDUFA11—female reproductive system—urinary bladder cancer	0.000531	0.00265	CbGeAlD
Metformin—NDUFAF4—female reproductive system—urinary bladder cancer	0.000527	0.00263	CbGeAlD
Metformin—NDUFB6—female reproductive system—urinary bladder cancer	0.000527	0.00263	CbGeAlD
Metformin—NDUFS1—female reproductive system—urinary bladder cancer	0.000523	0.00261	CbGeAlD
Metformin—NDUFC2—epithelium—urinary bladder cancer	0.000523	0.00261	CbGeAlD
Metformin—NDUFB10—female reproductive system—urinary bladder cancer	0.000519	0.00259	CbGeAlD
Metformin—NDUFA12—female reproductive system—urinary bladder cancer	0.000516	0.00257	CbGeAlD
Metformin—NDUFB7—female reproductive system—urinary bladder cancer	0.000516	0.00257	CbGeAlD
Metformin—PRKAB1—renal system—urinary bladder cancer	0.000514	0.00257	CbGeAlD
Metformin—NDUFS8—female reproductive system—urinary bladder cancer	0.000512	0.00255	CbGeAlD
Metformin—NDUFC1—vagina—urinary bladder cancer	0.000508	0.00254	CbGeAlD
Metformin—NDUFB5—female reproductive system—urinary bladder cancer	0.000505	0.00252	CbGeAlD
Metformin—NDUFA6—female reproductive system—urinary bladder cancer	0.000505	0.00252	CbGeAlD
Metformin—PRKAB1—urethra—urinary bladder cancer	0.000505	0.00252	CbGeAlD
Metformin—NDUFB2—vagina—urinary bladder cancer	0.000504	0.00251	CbGeAlD
Metformin—NDUFS4—female reproductive system—urinary bladder cancer	0.000502	0.0025	CbGeAlD
Metformin—NDUFA7—lymph node—urinary bladder cancer	0.000502	0.0025	CbGeAlD
Metformin—NDUFAF1—vagina—urinary bladder cancer	0.0005	0.00249	CbGeAlD
Metformin—NDUFB4—female reproductive system—urinary bladder cancer	0.000496	0.00247	CbGeAlD
Metformin—NDUFAB1—female reproductive system—urinary bladder cancer	0.000492	0.00246	CbGeAlD
Metformin—NDUFB3—vagina—urinary bladder cancer	0.000492	0.00245	CbGeAlD
Metformin—NDUFAF2—vagina—urinary bladder cancer	0.000492	0.00245	CbGeAlD
Metformin—NDUFA8—female reproductive system—urinary bladder cancer	0.000489	0.00244	CbGeAlD
Metformin—NDUFB9—female reproductive system—urinary bladder cancer	0.000489	0.00244	CbGeAlD
Metformin—NDUFA4—female reproductive system—urinary bladder cancer	0.000486	0.00243	CbGeAlD
Metformin—NDUFC2—renal system—urinary bladder cancer	0.000485	0.00242	CbGeAlD
Metformin—NDUFS2—smooth muscle tissue—urinary bladder cancer	0.000484	0.00241	CbGeAlD
Metformin—NDUFB11—female reproductive system—urinary bladder cancer	0.000484	0.00241	CbGeAlD
Metformin—NDUFV1—female reproductive system—urinary bladder cancer	0.000484	0.00241	CbGeAlD
Metformin—NDUFS5—female reproductive system—urinary bladder cancer	0.000481	0.0024	CbGeAlD
Metformin—NDUFB8—female reproductive system—urinary bladder cancer	0.000481	0.0024	CbGeAlD
Metformin—NDUFA11—vagina—urinary bladder cancer	0.00048	0.0024	CbGeAlD
Metformin—NDUFA5—vagina—urinary bladder cancer	0.00048	0.0024	CbGeAlD
Metformin—NDUFS3—smooth muscle tissue—urinary bladder cancer	0.000478	0.00238	CbGeAlD
Metformin—NDUFAF4—vagina—urinary bladder cancer	0.000477	0.00238	CbGeAlD
Metformin—NDUFB6—vagina—urinary bladder cancer	0.000477	0.00238	CbGeAlD
Metformin—NDUFC2—urethra—urinary bladder cancer	0.000476	0.00237	CbGeAlD
Metformin—NDUFB10—vagina—urinary bladder cancer	0.00047	0.00234	CbGeAlD
Metformin—NDUFA12—vagina—urinary bladder cancer	0.000467	0.00233	CbGeAlD
Metformin—NDUFB7—vagina—urinary bladder cancer	0.000467	0.00233	CbGeAlD
Metformin—NDUFS2—renal system—urinary bladder cancer	0.000466	0.00232	CbGeAlD
Metformin—NDUFB1—vagina—urinary bladder cancer	0.000463	0.00231	CbGeAlD
Metformin—NDUFS8—vagina—urinary bladder cancer	0.000463	0.00231	CbGeAlD
Metformin—NDUFS3—renal system—urinary bladder cancer	0.00046	0.0023	CbGeAlD
Metformin—NDUFS2—urethra—urinary bladder cancer	0.000458	0.00228	CbGeAlD
Metformin—NDUFB5—vagina—urinary bladder cancer	0.000457	0.00228	CbGeAlD
Metformin—NDUFA6—vagina—urinary bladder cancer	0.000457	0.00228	CbGeAlD
Metformin—NDUFS4—vagina—urinary bladder cancer	0.000454	0.00226	CbGeAlD
Metformin—NDUFS3—urethra—urinary bladder cancer	0.000452	0.00226	CbGeAlD
Metformin—NDUFS7—female reproductive system—urinary bladder cancer	0.00045	0.00225	CbGeAlD
Metformin—NDUFB4—vagina—urinary bladder cancer	0.000448	0.00224	CbGeAlD
Metformin—NDUFAB1—vagina—urinary bladder cancer	0.000445	0.00222	CbGeAlD
Metformin—NDUFB9—vagina—urinary bladder cancer	0.000443	0.00221	CbGeAlD
Metformin—NDUFA8—vagina—urinary bladder cancer	0.000443	0.00221	CbGeAlD
Metformin—NDUFA4—vagina—urinary bladder cancer	0.00044	0.00219	CbGeAlD
Metformin—NDUFB11—vagina—urinary bladder cancer	0.000437	0.00218	CbGeAlD
Metformin—NDUFV1—vagina—urinary bladder cancer	0.000437	0.00218	CbGeAlD
Metformin—NDUFS5—vagina—urinary bladder cancer	0.000435	0.00217	CbGeAlD
Metformin—NDUFB8—vagina—urinary bladder cancer	0.000435	0.00217	CbGeAlD
Metformin—PRKAB1—female reproductive system—urinary bladder cancer	0.000412	0.00205	CbGeAlD
Metformin—NDUFS7—vagina—urinary bladder cancer	0.000407	0.00203	CbGeAlD
Metformin—NDUFV2—lymph node—urinary bladder cancer	0.000401	0.002	CbGeAlD
Metformin—ND1—smooth muscle tissue—urinary bladder cancer	0.000397	0.00198	CbGeAlD
Metformin—NDUFA4L2—lymph node—urinary bladder cancer	0.00039	0.00195	CbGeAlD
Metformin—NDUFC2—female reproductive system—urinary bladder cancer	0.000388	0.00194	CbGeAlD
Metformin—ND1—renal system—urinary bladder cancer	0.000382	0.00191	CbGeAlD
Metformin—SLC47A1—prostate gland—urinary bladder cancer	0.000381	0.0019	CbGeAlD
Metformin—NDUFS2—female reproductive system—urinary bladder cancer	0.000373	0.00186	CbGeAlD
Metformin—PRKAB1—vagina—urinary bladder cancer	0.000373	0.00186	CbGeAlD
Metformin—NDUFS3—female reproductive system—urinary bladder cancer	0.000369	0.00184	CbGeAlD
Metformin—ND4L—lymph node—urinary bladder cancer	0.000367	0.00183	CbGeAlD
Metformin—ND5—lymph node—urinary bladder cancer	0.000367	0.00183	CbGeAlD
Metformin—ND2—lymph node—urinary bladder cancer	0.000367	0.00183	CbGeAlD
Metformin—ND3—lymph node—urinary bladder cancer	0.000367	0.00183	CbGeAlD
Metformin—ND4—lymph node—urinary bladder cancer	0.000355	0.00177	CbGeAlD
Metformin—NDUFC2—vagina—urinary bladder cancer	0.000351	0.00175	CbGeAlD
Metformin—NDUFA2—lymph node—urinary bladder cancer	0.000348	0.00173	CbGeAlD
Metformin—NDUFS2—vagina—urinary bladder cancer	0.000338	0.00168	CbGeAlD
Metformin—NDUFS3—vagina—urinary bladder cancer	0.000333	0.00166	CbGeAlD
Metformin—NDUFA10—lymph node—urinary bladder cancer	0.000332	0.00165	CbGeAlD
Metformin—NDUFC1—lymph node—urinary bladder cancer	0.000329	0.00164	CbGeAlD
Metformin—NDUFB2—lymph node—urinary bladder cancer	0.000326	0.00163	CbGeAlD
Metformin—NDUFAF1—lymph node—urinary bladder cancer	0.000323	0.00161	CbGeAlD
Metformin—SLC47A1—seminal vesicle—urinary bladder cancer	0.000322	0.00161	CbGeAlD
Metformin—ND6—lymph node—urinary bladder cancer	0.000321	0.0016	CbGeAlD
Metformin—NDUFAF2—lymph node—urinary bladder cancer	0.000318	0.00159	CbGeAlD
Metformin—NDUFB3—lymph node—urinary bladder cancer	0.000318	0.00159	CbGeAlD
Metformin—NDUFA11—lymph node—urinary bladder cancer	0.000311	0.00155	CbGeAlD
Metformin—NDUFA5—lymph node—urinary bladder cancer	0.000311	0.00155	CbGeAlD
Metformin—NDUFAF4—lymph node—urinary bladder cancer	0.000308	0.00154	CbGeAlD
Metformin—NDUFB6—lymph node—urinary bladder cancer	0.000308	0.00154	CbGeAlD
Metformin—SLC22A2—renal system—urinary bladder cancer	0.000307	0.00153	CbGeAlD
Metformin—ND1—female reproductive system—urinary bladder cancer	0.000306	0.00153	CbGeAlD
Metformin—NDUFS1—lymph node—urinary bladder cancer	0.000306	0.00153	CbGeAlD
Metformin—NDUFB10—lymph node—urinary bladder cancer	0.000304	0.00152	CbGeAlD
Metformin—SLC22A3—prostate gland—urinary bladder cancer	0.000304	0.00152	CbGeAlD
Metformin—NDUFB7—lymph node—urinary bladder cancer	0.000302	0.0015	CbGeAlD
Metformin—NDUFA12—lymph node—urinary bladder cancer	0.000302	0.0015	CbGeAlD
Metformin—NDUFB1—lymph node—urinary bladder cancer	0.0003	0.00149	CbGeAlD
Metformin—NDUFS8—lymph node—urinary bladder cancer	0.0003	0.00149	CbGeAlD
Metformin—NDUFB5—lymph node—urinary bladder cancer	0.000296	0.00147	CbGeAlD
Metformin—NDUFA6—lymph node—urinary bladder cancer	0.000296	0.00147	CbGeAlD
Metformin—NDUFS4—lymph node—urinary bladder cancer	0.000294	0.00146	CbGeAlD
Metformin—NDUFB4—lymph node—urinary bladder cancer	0.00029	0.00145	CbGeAlD
Metformin—NDUFAB1—lymph node—urinary bladder cancer	0.000288	0.00144	CbGeAlD
Metformin—NDUFA8—lymph node—urinary bladder cancer	0.000286	0.00143	CbGeAlD
Metformin—NDUFB9—lymph node—urinary bladder cancer	0.000286	0.00143	CbGeAlD
Metformin—NDUFA4—lymph node—urinary bladder cancer	0.000285	0.00142	CbGeAlD
Metformin—NDUFV1—lymph node—urinary bladder cancer	0.000283	0.00141	CbGeAlD
Metformin—NDUFB11—lymph node—urinary bladder cancer	0.000283	0.00141	CbGeAlD
Metformin—NDUFS5—lymph node—urinary bladder cancer	0.000281	0.0014	CbGeAlD
Metformin—NDUFB8—lymph node—urinary bladder cancer	0.000281	0.0014	CbGeAlD
Metformin—NDUFS7—lymph node—urinary bladder cancer	0.000263	0.00131	CbGeAlD
Metformin—SLC47A1—renal system—urinary bladder cancer	0.00026	0.0013	CbGeAlD
Metformin—SLC22A3—seminal vesicle—urinary bladder cancer	0.000257	0.00128	CbGeAlD
Metformin—SLC47A1—urethra—urinary bladder cancer	0.000255	0.00127	CbGeAlD
Metformin—PRKAB1—lymph node—urinary bladder cancer	0.000241	0.0012	CbGeAlD
Metformin—NDUFC2—lymph node—urinary bladder cancer	0.000227	0.00113	CbGeAlD
Metformin—NDUFS2—lymph node—urinary bladder cancer	0.000218	0.00109	CbGeAlD
Metformin—SLC22A1—renal system—urinary bladder cancer	0.000217	0.00108	CbGeAlD
Metformin—NDUFS3—lymph node—urinary bladder cancer	0.000216	0.00108	CbGeAlD
Metformin—SLC22A3—smooth muscle tissue—urinary bladder cancer	0.000215	0.00107	CbGeAlD
Metformin—SLC47A1—female reproductive system—urinary bladder cancer	0.000208	0.00104	CbGeAlD
Metformin—SLC22A3—renal system—urinary bladder cancer	0.000207	0.00103	CbGeAlD
Metformin—SLC22A3—urethra—urinary bladder cancer	0.000203	0.00101	CbGeAlD
Metformin—SLC47A1—vagina—urinary bladder cancer	0.000188	0.000938	CbGeAlD
Metformin—ND1—lymph node—urinary bladder cancer	0.000179	0.000893	CbGeAlD
Metformin—SLC22A3—female reproductive system—urinary bladder cancer	0.000166	0.000827	CbGeAlD
Metformin—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000159	0.00133	CcSEcCtD
Metformin—Pancreatitis—Epirubicin—urinary bladder cancer	0.000159	0.00133	CcSEcCtD
Metformin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000158	0.00133	CcSEcCtD
Metformin—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000158	0.00133	CcSEcCtD
Metformin—Angina pectoris—Epirubicin—urinary bladder cancer	0.000158	0.00132	CcSEcCtD
Metformin—SLC22A1—vagina—urinary bladder cancer	0.000157	0.000783	CbGeAlD
Metformin—Breast disorder—Doxorubicin—urinary bladder cancer	0.000157	0.00131	CcSEcCtD
Metformin—Anorexia—Etoposide—urinary bladder cancer	0.000156	0.00131	CcSEcCtD
Metformin—Diarrhoea—Thiotepa—urinary bladder cancer	0.000156	0.00131	CcSEcCtD
Metformin—Decreased appetite—Cisplatin—urinary bladder cancer	0.000156	0.00131	CcSEcCtD
Metformin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000156	0.00131	CcSEcCtD
Metformin—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000155	0.0013	CcSEcCtD
Metformin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000155	0.0013	CcSEcCtD
Metformin—Drowsiness—Methotrexate—urinary bladder cancer	0.000154	0.00129	CcSEcCtD
Metformin—Infestation NOS—Methotrexate—urinary bladder cancer	0.000154	0.00129	CcSEcCtD
Metformin—Infestation—Methotrexate—urinary bladder cancer	0.000154	0.00129	CcSEcCtD
Metformin—Hypotension—Etoposide—urinary bladder cancer	0.000153	0.00129	CcSEcCtD
Metformin—Neutropenia—Epirubicin—urinary bladder cancer	0.000151	0.00127	CcSEcCtD
Metformin—Dizziness—Thiotepa—urinary bladder cancer	0.000151	0.00127	CcSEcCtD
Metformin—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000151	0.00126	CcSEcCtD
Metformin—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.00015	0.00126	CcSEcCtD
Metformin—Urticaria—Fluorouracil—urinary bladder cancer	0.00015	0.00126	CcSEcCtD
Metformin—SLC22A3—vagina—urinary bladder cancer	0.00015	0.000748	CbGeAlD
Metformin—Influenza—Doxorubicin—urinary bladder cancer	0.00015	0.00125	CcSEcCtD
Metformin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000148	0.00124	CcSEcCtD
Metformin—Paraesthesia—Etoposide—urinary bladder cancer	0.000147	0.00124	CcSEcCtD
Metformin—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000147	0.00123	CcSEcCtD
Metformin—Dyspnoea—Etoposide—urinary bladder cancer	0.000146	0.00123	CcSEcCtD
Metformin—Somnolence—Etoposide—urinary bladder cancer	0.000146	0.00122	CcSEcCtD
Metformin—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000146	0.00122	CcSEcCtD
Metformin—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000146	0.00122	CcSEcCtD
Metformin—Vomiting—Thiotepa—urinary bladder cancer	0.000145	0.00122	CcSEcCtD
Metformin—Infestation NOS—Epirubicin—urinary bladder cancer	0.000144	0.00121	CcSEcCtD
Metformin—Drowsiness—Epirubicin—urinary bladder cancer	0.000144	0.00121	CcSEcCtD
Metformin—Infestation—Epirubicin—urinary bladder cancer	0.000144	0.00121	CcSEcCtD
Metformin—Rash—Thiotepa—urinary bladder cancer	0.000144	0.00121	CcSEcCtD
Metformin—Dermatitis—Thiotepa—urinary bladder cancer	0.000144	0.00121	CcSEcCtD
Metformin—Headache—Thiotepa—urinary bladder cancer	0.000143	0.0012	CcSEcCtD
Metformin—Decreased appetite—Etoposide—urinary bladder cancer	0.000143	0.0012	CcSEcCtD
Metformin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000142	0.00119	CcSEcCtD
Metformin—Fatigue—Etoposide—urinary bladder cancer	0.000141	0.00119	CcSEcCtD
Metformin—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000141	0.00119	CcSEcCtD
Metformin—Constipation—Etoposide—urinary bladder cancer	0.00014	0.00118	CcSEcCtD
Metformin—Neutropenia—Doxorubicin—urinary bladder cancer	0.00014	0.00117	CcSEcCtD
Metformin—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000139	0.00117	CcSEcCtD
Metformin—Hepatitis—Methotrexate—urinary bladder cancer	0.000138	0.00116	CcSEcCtD
Metformin—Asthenia—Gemcitabine—urinary bladder cancer	0.000138	0.00116	CcSEcCtD
Metformin—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000136	0.00114	CcSEcCtD
Metformin—Pruritus—Gemcitabine—urinary bladder cancer	0.000136	0.00114	CcSEcCtD
Metformin—Nausea—Thiotepa—urinary bladder cancer	0.000136	0.00114	CcSEcCtD
Metformin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000135	0.00113	CcSEcCtD
Metformin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000134	0.00112	CcSEcCtD
Metformin—Pruritus—Fluorouracil—urinary bladder cancer	0.000134	0.00112	CcSEcCtD
Metformin—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000133	0.00112	CcSEcCtD
Metformin—Infestation—Doxorubicin—urinary bladder cancer	0.000133	0.00112	CcSEcCtD
Metformin—Drowsiness—Doxorubicin—urinary bladder cancer	0.000133	0.00112	CcSEcCtD
Metformin—Bradycardia—Epirubicin—urinary bladder cancer	0.000132	0.0011	CcSEcCtD
Metformin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000132	0.0011	CcSEcCtD
Metformin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000131	0.0011	CcSEcCtD
Metformin—Urticaria—Etoposide—urinary bladder cancer	0.00013	0.00109	CcSEcCtD
Metformin—Rhinitis—Epirubicin—urinary bladder cancer	0.00013	0.00109	CcSEcCtD
Metformin—Abdominal pain—Etoposide—urinary bladder cancer	0.00013	0.00109	CcSEcCtD
Metformin—Hepatitis—Epirubicin—urinary bladder cancer	0.000129	0.00109	CcSEcCtD
Metformin—Eye disorder—Methotrexate—urinary bladder cancer	0.000129	0.00108	CcSEcCtD
Metformin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000129	0.00108	CcSEcCtD
Metformin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000129	0.00108	CcSEcCtD
Metformin—Asthenia—Cisplatin—urinary bladder cancer	0.000129	0.00108	CcSEcCtD
Metformin—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000128	0.00108	CcSEcCtD
Metformin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000128	0.00107	CcSEcCtD
Metformin—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000127	0.00107	CcSEcCtD
Metformin—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000126	0.00106	CcSEcCtD
Metformin—Angiopathy—Methotrexate—urinary bladder cancer	0.000126	0.00105	CcSEcCtD
Metformin—Immune system disorder—Methotrexate—urinary bladder cancer	0.000125	0.00105	CcSEcCtD
Metformin—Dizziness—Fluorouracil—urinary bladder cancer	0.000125	0.00105	CcSEcCtD
Metformin—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000125	0.00105	CcSEcCtD
Metformin—Chills—Methotrexate—urinary bladder cancer	0.000124	0.00104	CcSEcCtD
Metformin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000123	0.00103	CcSEcCtD
Metformin—Vomiting—Gemcitabine—urinary bladder cancer	0.000122	0.00102	CcSEcCtD
Metformin—Bradycardia—Doxorubicin—urinary bladder cancer	0.000122	0.00102	CcSEcCtD
Metformin—SLC47A1—lymph node—urinary bladder cancer	0.000122	0.000607	CbGeAlD
Metformin—Rash—Gemcitabine—urinary bladder cancer	0.000121	0.00102	CcSEcCtD
Metformin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000121	0.00101	CcSEcCtD
Metformin—Eye disorder—Epirubicin—urinary bladder cancer	0.000121	0.00101	CcSEcCtD
Metformin—Erythema—Methotrexate—urinary bladder cancer	0.00012	0.00101	CcSEcCtD
Metformin—Malnutrition—Methotrexate—urinary bladder cancer	0.00012	0.00101	CcSEcCtD
Metformin—Headache—Gemcitabine—urinary bladder cancer	0.00012	0.00101	CcSEcCtD
Metformin—Flushing—Epirubicin—urinary bladder cancer	0.00012	0.00101	CcSEcCtD
Metformin—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00012	0.00101	CcSEcCtD
Metformin—Vomiting—Fluorouracil—urinary bladder cancer	0.00012	0.00101	CcSEcCtD
Metformin—Rhinitis—Doxorubicin—urinary bladder cancer	0.00012	0.00101	CcSEcCtD
Metformin—Hepatitis—Doxorubicin—urinary bladder cancer	0.00012	0.001	CcSEcCtD
Metformin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000119	0.000999	CcSEcCtD
Metformin—Rash—Fluorouracil—urinary bladder cancer	0.000119	0.000999	CcSEcCtD
Metformin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000119	0.000998	CcSEcCtD
Metformin—Headache—Fluorouracil—urinary bladder cancer	0.000118	0.000992	CcSEcCtD
Metformin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000118	0.000989	CcSEcCtD
Metformin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000118	0.000989	CcSEcCtD
Metformin—Asthenia—Etoposide—urinary bladder cancer	0.000118	0.000987	CcSEcCtD
Metformin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000118	0.000987	CcSEcCtD
Metformin—Angiopathy—Epirubicin—urinary bladder cancer	0.000117	0.000985	CcSEcCtD
Metformin—Immune system disorder—Epirubicin—urinary bladder cancer	0.000117	0.00098	CcSEcCtD
Metformin—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000117	0.000978	CcSEcCtD
Metformin—Chills—Epirubicin—urinary bladder cancer	0.000116	0.000974	CcSEcCtD
Metformin—Pruritus—Etoposide—urinary bladder cancer	0.000116	0.000973	CcSEcCtD
Metformin—Nausea—Gemcitabine—urinary bladder cancer	0.000114	0.000957	CcSEcCtD
Metformin—Vomiting—Cisplatin—urinary bladder cancer	0.000114	0.000955	CcSEcCtD
Metformin—Vision blurred—Methotrexate—urinary bladder cancer	0.000114	0.000952	CcSEcCtD
Metformin—Rash—Cisplatin—urinary bladder cancer	0.000113	0.000947	CcSEcCtD
Metformin—Dermatitis—Cisplatin—urinary bladder cancer	0.000113	0.000946	CcSEcCtD
Metformin—Erythema—Epirubicin—urinary bladder cancer	0.000113	0.000945	CcSEcCtD
Metformin—Malnutrition—Epirubicin—urinary bladder cancer	0.000113	0.000945	CcSEcCtD
Metformin—Diarrhoea—Etoposide—urinary bladder cancer	0.000112	0.000941	CcSEcCtD
Metformin—Nausea—Fluorouracil—urinary bladder cancer	0.000112	0.000941	CcSEcCtD
Metformin—Eye disorder—Doxorubicin—urinary bladder cancer	0.000112	0.000939	CcSEcCtD
Metformin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000112	0.000937	CcSEcCtD
Metformin—Flushing—Doxorubicin—urinary bladder cancer	0.000111	0.000932	CcSEcCtD
Metformin—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000111	0.000932	CcSEcCtD
Metformin—Flatulence—Epirubicin—urinary bladder cancer	0.000111	0.000931	CcSEcCtD
Metformin—Dysgeusia—Epirubicin—urinary bladder cancer	0.00011	0.000925	CcSEcCtD
Metformin—Angiopathy—Doxorubicin—urinary bladder cancer	0.000109	0.000911	CcSEcCtD
Metformin—Malaise—Methotrexate—urinary bladder cancer	0.000109	0.00091	CcSEcCtD
Metformin—Dizziness—Etoposide—urinary bladder cancer	0.000109	0.00091	CcSEcCtD
Metformin—Muscle spasms—Epirubicin—urinary bladder cancer	0.000108	0.000908	CcSEcCtD
Metformin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000108	0.000907	CcSEcCtD
Metformin—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000108	0.000905	CcSEcCtD
Metformin—Chills—Doxorubicin—urinary bladder cancer	0.000108	0.000901	CcSEcCtD
Metformin—Nausea—Cisplatin—urinary bladder cancer	0.000106	0.000892	CcSEcCtD
Metformin—Vision blurred—Epirubicin—urinary bladder cancer	0.000106	0.00089	CcSEcCtD
Metformin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000105	0.000877	CcSEcCtD
Metformin—Vomiting—Etoposide—urinary bladder cancer	0.000104	0.000875	CcSEcCtD
Metformin—Erythema—Doxorubicin—urinary bladder cancer	0.000104	0.000874	CcSEcCtD
Metformin—Malnutrition—Doxorubicin—urinary bladder cancer	0.000104	0.000874	CcSEcCtD
Metformin—Rash—Etoposide—urinary bladder cancer	0.000103	0.000867	CcSEcCtD
Metformin—Dermatitis—Etoposide—urinary bladder cancer	0.000103	0.000867	CcSEcCtD
Metformin—Headache—Etoposide—urinary bladder cancer	0.000103	0.000862	CcSEcCtD
Metformin—Flatulence—Doxorubicin—urinary bladder cancer	0.000103	0.000861	CcSEcCtD
Metformin—Chest pain—Methotrexate—urinary bladder cancer	0.000103	0.00086	CcSEcCtD
Metformin—Myalgia—Methotrexate—urinary bladder cancer	0.000103	0.00086	CcSEcCtD
Metformin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000102	0.000856	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000102	0.000854	CcSEcCtD
Metformin—Malaise—Epirubicin—urinary bladder cancer	0.000102	0.000852	CcSEcCtD
Metformin—Discomfort—Methotrexate—urinary bladder cancer	0.000101	0.000849	CcSEcCtD
Metformin—Syncope—Epirubicin—urinary bladder cancer	0.000101	0.000847	CcSEcCtD
Metformin—Muscle spasms—Doxorubicin—urinary bladder cancer	0.0001	0.000841	CcSEcCtD
Metformin—Palpitations—Epirubicin—urinary bladder cancer	9.96e-05	0.000835	CcSEcCtD
Metformin—Loss of consciousness—Epirubicin—urinary bladder cancer	9.91e-05	0.00083	CcSEcCtD
Metformin—Vision blurred—Doxorubicin—urinary bladder cancer	9.83e-05	0.000824	CcSEcCtD
Metformin—Infection—Methotrexate—urinary bladder cancer	9.77e-05	0.000819	CcSEcCtD
Metformin—Nausea—Etoposide—urinary bladder cancer	9.75e-05	0.000817	CcSEcCtD
Metformin—Hypertension—Epirubicin—urinary bladder cancer	9.73e-05	0.000816	CcSEcCtD
Metformin—SLC22A3—lymph node—urinary bladder cancer	9.7e-05	0.000484	CbGeAlD
Metformin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	9.68e-05	0.000811	CcSEcCtD
Metformin—Nervous system disorder—Methotrexate—urinary bladder cancer	9.64e-05	0.000808	CcSEcCtD
Metformin—Thrombocytopenia—Methotrexate—urinary bladder cancer	9.63e-05	0.000807	CcSEcCtD
Metformin—Chest pain—Epirubicin—urinary bladder cancer	9.6e-05	0.000804	CcSEcCtD
Metformin—Myalgia—Epirubicin—urinary bladder cancer	9.6e-05	0.000804	CcSEcCtD
Metformin—Skin disorder—Methotrexate—urinary bladder cancer	9.55e-05	0.0008	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	9.53e-05	0.000799	CcSEcCtD
Metformin—Hyperhidrosis—Methotrexate—urinary bladder cancer	9.5e-05	0.000797	CcSEcCtD
Metformin—Discomfort—Epirubicin—urinary bladder cancer	9.48e-05	0.000795	CcSEcCtD
Metformin—Malaise—Doxorubicin—urinary bladder cancer	9.41e-05	0.000788	CcSEcCtD
Metformin—Anorexia—Methotrexate—urinary bladder cancer	9.37e-05	0.000785	CcSEcCtD
Metformin—Syncope—Doxorubicin—urinary bladder cancer	9.35e-05	0.000784	CcSEcCtD
Metformin—Palpitations—Doxorubicin—urinary bladder cancer	9.22e-05	0.000773	CcSEcCtD
Metformin—Oedema—Epirubicin—urinary bladder cancer	9.2e-05	0.000771	CcSEcCtD
Metformin—Hypotension—Methotrexate—urinary bladder cancer	9.19e-05	0.00077	CcSEcCtD
Metformin—Loss of consciousness—Doxorubicin—urinary bladder cancer	9.17e-05	0.000768	CcSEcCtD
Metformin—Infection—Epirubicin—urinary bladder cancer	9.14e-05	0.000766	CcSEcCtD
Metformin—Shock—Epirubicin—urinary bladder cancer	9.05e-05	0.000759	CcSEcCtD
Metformin—Nervous system disorder—Epirubicin—urinary bladder cancer	9.02e-05	0.000756	CcSEcCtD
Metformin—Thrombocytopenia—Epirubicin—urinary bladder cancer	9.01e-05	0.000755	CcSEcCtD
Metformin—Hypertension—Doxorubicin—urinary bladder cancer	9e-05	0.000755	CcSEcCtD
Metformin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	8.96e-05	0.000751	CcSEcCtD
Metformin—Skin disorder—Epirubicin—urinary bladder cancer	8.94e-05	0.000749	CcSEcCtD
Metformin—Hyperhidrosis—Epirubicin—urinary bladder cancer	8.89e-05	0.000745	CcSEcCtD
Metformin—Chest pain—Doxorubicin—urinary bladder cancer	8.88e-05	0.000744	CcSEcCtD
Metformin—Myalgia—Doxorubicin—urinary bladder cancer	8.88e-05	0.000744	CcSEcCtD
Metformin—Paraesthesia—Methotrexate—urinary bladder cancer	8.83e-05	0.00074	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	8.82e-05	0.000739	CcSEcCtD
Metformin—Discomfort—Doxorubicin—urinary bladder cancer	8.77e-05	0.000735	CcSEcCtD
Metformin—Anorexia—Epirubicin—urinary bladder cancer	8.77e-05	0.000735	CcSEcCtD
Metformin—Dyspnoea—Methotrexate—urinary bladder cancer	8.76e-05	0.000735	CcSEcCtD
Metformin—Somnolence—Methotrexate—urinary bladder cancer	8.74e-05	0.000733	CcSEcCtD
Metformin—Dyspepsia—Methotrexate—urinary bladder cancer	8.65e-05	0.000725	CcSEcCtD
Metformin—Hypotension—Epirubicin—urinary bladder cancer	8.6e-05	0.000721	CcSEcCtD
Metformin—Decreased appetite—Methotrexate—urinary bladder cancer	8.55e-05	0.000716	CcSEcCtD
Metformin—Oedema—Doxorubicin—urinary bladder cancer	8.51e-05	0.000714	CcSEcCtD
Metformin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	8.49e-05	0.000711	CcSEcCtD
Metformin—Fatigue—Methotrexate—urinary bladder cancer	8.48e-05	0.00071	CcSEcCtD
Metformin—Infection—Doxorubicin—urinary bladder cancer	8.46e-05	0.000709	CcSEcCtD
Metformin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	8.38e-05	0.000703	CcSEcCtD
Metformin—Shock—Doxorubicin—urinary bladder cancer	8.37e-05	0.000702	CcSEcCtD
Metformin—Nervous system disorder—Doxorubicin—urinary bladder cancer	8.35e-05	0.0007	CcSEcCtD
Metformin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	8.33e-05	0.000699	CcSEcCtD
Metformin—Skin disorder—Doxorubicin—urinary bladder cancer	8.27e-05	0.000693	CcSEcCtD
Metformin—Paraesthesia—Epirubicin—urinary bladder cancer	8.26e-05	0.000692	CcSEcCtD
Metformin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	8.23e-05	0.00069	CcSEcCtD
Metformin—Dyspnoea—Epirubicin—urinary bladder cancer	8.2e-05	0.000687	CcSEcCtD
Metformin—Somnolence—Epirubicin—urinary bladder cancer	8.18e-05	0.000686	CcSEcCtD
Metformin—Anorexia—Doxorubicin—urinary bladder cancer	8.11e-05	0.00068	CcSEcCtD
Metformin—Feeling abnormal—Methotrexate—urinary bladder cancer	8.1e-05	0.000679	CcSEcCtD
Metformin—Dyspepsia—Epirubicin—urinary bladder cancer	8.1e-05	0.000679	CcSEcCtD
Metformin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	8.04e-05	0.000674	CcSEcCtD
Metformin—Decreased appetite—Epirubicin—urinary bladder cancer	8e-05	0.00067	CcSEcCtD
Metformin—Hypotension—Doxorubicin—urinary bladder cancer	7.95e-05	0.000667	CcSEcCtD
Metformin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	7.94e-05	0.000666	CcSEcCtD
Metformin—Fatigue—Epirubicin—urinary bladder cancer	7.93e-05	0.000665	CcSEcCtD
Metformin—Constipation—Epirubicin—urinary bladder cancer	7.87e-05	0.000659	CcSEcCtD
Metformin—Urticaria—Methotrexate—urinary bladder cancer	7.81e-05	0.000655	CcSEcCtD
Metformin—Abdominal pain—Methotrexate—urinary bladder cancer	7.77e-05	0.000651	CcSEcCtD
Metformin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	7.76e-05	0.00065	CcSEcCtD
Metformin—Paraesthesia—Doxorubicin—urinary bladder cancer	7.64e-05	0.000641	CcSEcCtD
Metformin—Dyspnoea—Doxorubicin—urinary bladder cancer	7.59e-05	0.000636	CcSEcCtD
Metformin—Feeling abnormal—Epirubicin—urinary bladder cancer	7.58e-05	0.000635	CcSEcCtD
Metformin—Somnolence—Doxorubicin—urinary bladder cancer	7.57e-05	0.000634	CcSEcCtD
Metformin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	7.52e-05	0.000631	CcSEcCtD
Metformin—Dyspepsia—Doxorubicin—urinary bladder cancer	7.49e-05	0.000628	CcSEcCtD
Metformin—Decreased appetite—Doxorubicin—urinary bladder cancer	7.4e-05	0.00062	CcSEcCtD
Metformin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	7.35e-05	0.000616	CcSEcCtD
Metformin—Fatigue—Doxorubicin—urinary bladder cancer	7.34e-05	0.000615	CcSEcCtD
Metformin—Urticaria—Epirubicin—urinary bladder cancer	7.31e-05	0.000613	CcSEcCtD
Metformin—Constipation—Doxorubicin—urinary bladder cancer	7.28e-05	0.00061	CcSEcCtD
Metformin—Abdominal pain—Epirubicin—urinary bladder cancer	7.27e-05	0.00061	CcSEcCtD
Metformin—Asthenia—Methotrexate—urinary bladder cancer	7.05e-05	0.000591	CcSEcCtD
Metformin—Feeling abnormal—Doxorubicin—urinary bladder cancer	7.01e-05	0.000588	CcSEcCtD
Metformin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	6.96e-05	0.000583	CcSEcCtD
Metformin—Pruritus—Methotrexate—urinary bladder cancer	6.96e-05	0.000583	CcSEcCtD
Metformin—Urticaria—Doxorubicin—urinary bladder cancer	6.76e-05	0.000567	CcSEcCtD
Metformin—Abdominal pain—Doxorubicin—urinary bladder cancer	6.73e-05	0.000564	CcSEcCtD
Metformin—Diarrhoea—Methotrexate—urinary bladder cancer	6.73e-05	0.000564	CcSEcCtD
Metformin—Asthenia—Epirubicin—urinary bladder cancer	6.6e-05	0.000553	CcSEcCtD
Metformin—Pruritus—Epirubicin—urinary bladder cancer	6.51e-05	0.000546	CcSEcCtD
Metformin—Dizziness—Methotrexate—urinary bladder cancer	6.5e-05	0.000545	CcSEcCtD
Metformin—Diarrhoea—Epirubicin—urinary bladder cancer	6.29e-05	0.000528	CcSEcCtD
Metformin—Vomiting—Methotrexate—urinary bladder cancer	6.25e-05	0.000524	CcSEcCtD
Metformin—Rash—Methotrexate—urinary bladder cancer	6.2e-05	0.00052	CcSEcCtD
Metformin—Dermatitis—Methotrexate—urinary bladder cancer	6.19e-05	0.000519	CcSEcCtD
Metformin—Headache—Methotrexate—urinary bladder cancer	6.16e-05	0.000516	CcSEcCtD
Metformin—Asthenia—Doxorubicin—urinary bladder cancer	6.11e-05	0.000512	CcSEcCtD
Metformin—Dizziness—Epirubicin—urinary bladder cancer	6.08e-05	0.00051	CcSEcCtD
Metformin—Pruritus—Doxorubicin—urinary bladder cancer	6.02e-05	0.000505	CcSEcCtD
Metformin—Vomiting—Epirubicin—urinary bladder cancer	5.85e-05	0.00049	CcSEcCtD
Metformin—Nausea—Methotrexate—urinary bladder cancer	5.84e-05	0.000489	CcSEcCtD
Metformin—Diarrhoea—Doxorubicin—urinary bladder cancer	5.82e-05	0.000488	CcSEcCtD
Metformin—Rash—Epirubicin—urinary bladder cancer	5.8e-05	0.000486	CcSEcCtD
Metformin—Dermatitis—Epirubicin—urinary bladder cancer	5.8e-05	0.000486	CcSEcCtD
Metformin—Headache—Epirubicin—urinary bladder cancer	5.76e-05	0.000483	CcSEcCtD
Metformin—Dizziness—Doxorubicin—urinary bladder cancer	5.63e-05	0.000472	CcSEcCtD
Metformin—Nausea—Epirubicin—urinary bladder cancer	5.46e-05	0.000458	CcSEcCtD
Metformin—Vomiting—Doxorubicin—urinary bladder cancer	5.41e-05	0.000454	CcSEcCtD
Metformin—Rash—Doxorubicin—urinary bladder cancer	5.37e-05	0.00045	CcSEcCtD
Metformin—Dermatitis—Doxorubicin—urinary bladder cancer	5.36e-05	0.000449	CcSEcCtD
Metformin—Headache—Doxorubicin—urinary bladder cancer	5.33e-05	0.000447	CcSEcCtD
Metformin—Nausea—Doxorubicin—urinary bladder cancer	5.06e-05	0.000424	CcSEcCtD
Metformin—NDUFB9—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—ND4L—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—ND3—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—ND2—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—ND4—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—ND6—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—ND5—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000205	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTZ1—urinary bladder cancer	2.55e-05	0.000202	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—EP300—urinary bladder cancer	2.53e-05	0.0002	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TSC1—urinary bladder cancer	2.5e-05	0.000198	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PPARG—urinary bladder cancer	2.49e-05	0.000197	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PPARG—urinary bladder cancer	2.49e-05	0.000197	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PPARG—urinary bladder cancer	2.49e-05	0.000197	CbGpPWpGaD
Metformin—ND1—Metabolism—GSTP1—urinary bladder cancer	2.44e-05	0.000193	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PTEN—urinary bladder cancer	2.43e-05	0.000192	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PTEN—urinary bladder cancer	2.43e-05	0.000192	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PTEN—urinary bladder cancer	2.43e-05	0.000192	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PTEN—urinary bladder cancer	2.43e-05	0.000192	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTO2—urinary bladder cancer	2.42e-05	0.000192	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NAT1—urinary bladder cancer	2.42e-05	0.000192	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—CREBBP—urinary bladder cancer	2.4e-05	0.00019	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—CREBBP—urinary bladder cancer	2.4e-05	0.00019	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—CREBBP—urinary bladder cancer	2.4e-05	0.00019	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTZ1—urinary bladder cancer	2.38e-05	0.000188	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—JAG1—urinary bladder cancer	2.38e-05	0.000188	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PPARG—urinary bladder cancer	2.34e-05	0.000186	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—TYMP—urinary bladder cancer	2.34e-05	0.000185	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—EP300—urinary bladder cancer	2.32e-05	0.000183	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—EP300—urinary bladder cancer	2.32e-05	0.000183	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—EP300—urinary bladder cancer	2.32e-05	0.000183	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—EP300—urinary bladder cancer	2.32e-05	0.000183	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTGS2—urinary bladder cancer	2.31e-05	0.000183	CbGpPWpGaD
Metformin—ND1—Metabolism—TYMS—urinary bladder cancer	2.27e-05	0.00018	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—ND4L—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—ND4—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—ND3—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—ND5—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—ND2—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—ND6—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTO2—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NAT1—urinary bladder cancer	2.26e-05	0.000179	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—CREBBP—urinary bladder cancer	2.25e-05	0.000178	CbGpPWpGaD
Metformin—ND1—Metabolism—NCOR1—urinary bladder cancer	2.24e-05	0.000178	CbGpPWpGaD
Metformin—ND1—Metabolism—GSTM1—urinary bladder cancer	2.24e-05	0.000178	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—UGT2B7—urinary bladder cancer	2.21e-05	0.000175	CbGpPWpGaD
Metformin—ND3—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—ND6—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—ND5—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—ND4—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—ND2—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—ND4L—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—ND1—Metabolism—GPX1—urinary bladder cancer	2.15e-05	0.00017	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NAT2—urinary bladder cancer	2.12e-05	0.000167	CbGpPWpGaD
Metformin—ND1—Metabolism—ERCC2—urinary bladder cancer	2.11e-05	0.000167	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—UGT2B7—urinary bladder cancer	2.06e-05	0.000163	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.06e-05	0.000163	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTEN—urinary bladder cancer	2.01e-05	0.000159	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP4B1—urinary bladder cancer	1.99e-05	0.000158	CbGpPWpGaD
Metformin—ND1—Metabolism—MTHFR—urinary bladder cancer	1.98e-05	0.000157	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTGS2—urinary bladder cancer	1.96e-05	0.000155	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTGS2—urinary bladder cancer	1.96e-05	0.000155	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTGS2—urinary bladder cancer	1.96e-05	0.000155	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—S100B—urinary bladder cancer	1.92e-05	0.000152	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—EP300—urinary bladder cancer	1.92e-05	0.000152	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.92e-05	0.000152	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC19A1—urinary bladder cancer	1.88e-05	0.000149	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP4B1—urinary bladder cancer	1.86e-05	0.000147	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTGS2—urinary bladder cancer	1.84e-05	0.000146	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PRSS3—urinary bladder cancer	1.84e-05	0.000145	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—RRM2—urinary bladder cancer	1.83e-05	0.000145	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC19A1—urinary bladder cancer	1.76e-05	0.000139	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NCOR1—urinary bladder cancer	1.73e-05	0.000137	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTEN—urinary bladder cancer	1.71e-05	0.000135	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTEN—urinary bladder cancer	1.71e-05	0.000135	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTEN—urinary bladder cancer	1.71e-05	0.000135	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PRSS3—urinary bladder cancer	1.71e-05	0.000135	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ENO2—urinary bladder cancer	1.69e-05	0.000134	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—HPGDS—urinary bladder cancer	1.69e-05	0.000134	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTT1—urinary bladder cancer	1.64e-05	0.00013	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—EP300—urinary bladder cancer	1.63e-05	0.000129	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—EP300—urinary bladder cancer	1.63e-05	0.000129	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—EP300—urinary bladder cancer	1.63e-05	0.000129	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTEN—urinary bladder cancer	1.61e-05	0.000127	CbGpPWpGaD
Metformin—ND1—Metabolism—PPARG—urinary bladder cancer	1.61e-05	0.000127	CbGpPWpGaD
Metformin—ND1—Metabolism—CREBBP—urinary bladder cancer	1.54e-05	0.000122	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.54e-05	0.000122	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—EP300—urinary bladder cancer	1.53e-05	0.000121	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TERT—urinary bladder cancer	1.53e-05	0.000121	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TYMP—urinary bladder cancer	1.47e-05	0.000116	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FGFR3—urinary bladder cancer	1.4e-05	0.000111	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TYMP—urinary bladder cancer	1.37e-05	0.000108	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NQO1—urinary bladder cancer	1.36e-05	0.000108	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ESR1—urinary bladder cancer	1.36e-05	0.000108	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NAT2—urinary bladder cancer	1.33e-05	0.000105	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—urinary bladder cancer	1.26e-05	0.0001	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NAT2—urinary bladder cancer	1.24e-05	9.79e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CREBBP—urinary bladder cancer	1.19e-05	9.43e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IGF1—urinary bladder cancer	1.18e-05	9.31e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—RRM2—urinary bladder cancer	1.15e-05	9.07e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTP1—urinary bladder cancer	1.14e-05	9e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTEN—urinary bladder cancer	1.1e-05	8.73e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	1.09e-05	8.63e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—RHOA—urinary bladder cancer	1.08e-05	8.53e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—RRM2—urinary bladder cancer	1.07e-05	8.45e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HPGDS—urinary bladder cancer	1.06e-05	8.4e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ENO2—urinary bladder cancer	1.06e-05	8.4e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—TYMS—urinary bladder cancer	1.06e-05	8.37e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—EP300—urinary bladder cancer	1.05e-05	8.32e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NCOR1—urinary bladder cancer	1.04e-05	8.27e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTM1—urinary bladder cancer	1.04e-05	8.27e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTT1—urinary bladder cancer	1.03e-05	8.14e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	1.02e-05	8.04e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GPX1—urinary bladder cancer	1e-05	7.92e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ERBB2—urinary bladder cancer	9.98e-06	7.9e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HPGDS—urinary bladder cancer	9.89e-06	7.83e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ENO2—urinary bladder cancer	9.89e-06	7.83e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ERCC2—urinary bladder cancer	9.82e-06	7.78e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.63e-06	7.62e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTT1—urinary bladder cancer	9.59e-06	7.59e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CXCL8—urinary bladder cancer	9.46e-06	7.49e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—MTHFR—urinary bladder cancer	9.23e-06	7.31e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL2—urinary bladder cancer	9.04e-06	7.16e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.98e-06	7.11e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCND1—urinary bladder cancer	8.82e-06	6.98e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MMP9—urinary bladder cancer	8.56e-06	6.77e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NQO1—urinary bladder cancer	8.55e-06	6.77e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1A—urinary bladder cancer	8.53e-06	6.75e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTEN—urinary bladder cancer	8.51e-06	6.73e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—HRAS—urinary bladder cancer	8.35e-06	6.61e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EP300—urinary bladder cancer	8.11e-06	6.42e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NQO1—urinary bladder cancer	7.97e-06	6.31e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SRC—urinary bladder cancer	7.89e-06	6.25e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—HRAS—urinary bladder cancer	7.78e-06	6.16e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPARG—urinary bladder cancer	7.49e-06	5.93e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CREBBP—urinary bladder cancer	7.19e-06	5.69e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTP1—urinary bladder cancer	7.13e-06	5.64e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MYC—urinary bladder cancer	7.07e-06	5.6e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGFR—urinary bladder cancer	6.92e-06	5.47e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTP1—urinary bladder cancer	6.65e-06	5.26e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TYMS—urinary bladder cancer	6.63e-06	5.25e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTM1—urinary bladder cancer	6.55e-06	5.19e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NCOR1—urinary bladder cancer	6.55e-06	5.19e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KRAS—urinary bladder cancer	6.53e-06	5.17e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GPX1—urinary bladder cancer	6.28e-06	4.97e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TYMS—urinary bladder cancer	6.18e-06	4.89e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ERCC2—urinary bladder cancer	6.16e-06	4.88e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	6.11e-06	4.83e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	6.11e-06	4.83e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—urinary bladder cancer	5.89e-06	4.66e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GPX1—urinary bladder cancer	5.85e-06	4.63e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—urinary bladder cancer	5.81e-06	4.6e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—MTHFR—urinary bladder cancer	5.79e-06	4.58e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	5.74e-06	4.55e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HRAS—urinary bladder cancer	5.55e-06	4.4e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	5.4e-06	4.27e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTEN—urinary bladder cancer	5.14e-06	4.07e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—EP300—urinary bladder cancer	4.9e-06	3.88e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPARG—urinary bladder cancer	4.7e-06	3.72e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CREBBP—urinary bladder cancer	4.51e-06	3.57e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPARG—urinary bladder cancer	4.38e-06	3.46e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	4.2e-06	3.33e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—urinary bladder cancer	3.69e-06	2.92e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	3.44e-06	2.73e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTEN—urinary bladder cancer	3.22e-06	2.55e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—EP300—urinary bladder cancer	3.07e-06	2.43e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTEN—urinary bladder cancer	3e-06	2.38e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—EP300—urinary bladder cancer	2.86e-06	2.27e-05	CbGpPWpGaD
